Evidence map›Paper›PMID 27045364›Full record

ArticlePLoS neglected tropical diseases2016

Severe Fever with Thrombocytopenia Syndrome Virus Antigen Detection Using Monoclonal Antibodies to the Nucleocapsid Protein.

Aiko Fukuma, Shuetsu Fukushi, Tomoki Yoshikawa, Hideki Tani, Satoshi Taniguchi, Takeshi Kurosu, Kazutaka Egawa, Yuto Suda, Harpal Singh, Taro Nomachi and 13 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Emerging Tick-BorneMicroorganisms · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 1 country.

Aiko FukumaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Shuetsu FukushiDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Tomoki YoshikawaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Hideki TaniDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Satoshi TaniguchiDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Takeshi KurosuDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Kazutaka EgawaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Yuto SudaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Harpal SinghDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Taro NomachiMiyazaki Prefectural Institute for Public Health and Environment, Miyazaki, Japan.
Mutsuyo GokudenKagoshima Prefectural Institute for Environmental Research and Public Health, Kagoshima, Japan.
Katsuyuki AndoSaga Prefectural Institute of Public Health and Pharmaceutical Research, Saga, Japan.
Kouji KidaOkayama Prefectural Institute for Public Health and Environmental Science, Okayama, Japan.
Miki KanEhime Prefectural Institute of Public Health and Environmental Science, Ehime, Japan.
Nobuyuki KatoHealth and Sanitation Office, Tottori Prefecture Institute of Public Health and Environmental Science, Tottori, Japan.
Akira YoshikawaNagasaki Prefectural Institute for Environmental Research and Public Health, Public Health Science Research Center, Nagasaki, Japan.
Hiroaki KitamotoHyogo Prefectural Institute of Public Health and Consumer Sciences, Hyogo-ku Kobe-shi, Japan.
Yuko SatoDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Hideki HasegawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Shigeru MorikawaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki ShimojimaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki SaijoDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
National Institute of Infectious Diseases · JPHyogo Prefectural Institute of Environmental Sciences · JPKagoshima Prefectural Institute For Education Research · JPMiyazaki Prefectural Hospital · JPOkayama Prefectural University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease with a high case fatality rate, and is caused by the SFTS virus (SFTSV). SFTS is endemic to China, South Korea, and Japan. The viral RNA level in sera of patients with SFTS is known to be strongly associated with outcomes. Virological SFTS diagnosis with high sensitivity and specificity are required in disease endemic areas. METHODOLOGY/PRINCIPAL

findingsWe generated novel monoclonal antibodies (MAbs) against the SFTSV nucleocapsid (N) protein and developed a sandwich antigen (Ag)-capture enzyme-linked immunosorbent assay (ELISA) for the detection of N protein of SFTSV using MAb and polyclonal antibody as capture and detection antibodies, respectively. The Ag-capture system was capable of detecting at least 350-1220 TCID50/100 μl/well from the culture supernatants of various SFTSV strains. The efficacy of the Ag-capture ELISA in SFTS diagnosis was evaluated using serum samples collected from patients suspected of having SFTS in Japan. All 24 serum samples (100%) containing high copy numbers of viral RNA (>105 copies/ml) showed a positive reaction in the Ag-capture ELISA, whereas 12 out of 15 serum samples (80%) containing low copy numbers of viral RNA (<105 copies/ml) showed a negative reaction in the Ag-capture ELISA. Among these Ag-capture ELISA-negative 12 samples, 9 (75%) were positive for IgG antibodies against SFTSV.

conclusionsThe newly developed Ag-capture ELISA is useful for SFTS diagnosis in acute phase patients with high levels of viremia.

Indexed as

Antibodies, MonoclonalAntibodies, ViralAntigens, ViralBunyaviridae InfectionsDiagnostic Tests, RoutineEnzyme-Linked Immunosorbent AssayHumansNucleocapsid ProteinsPhlebovirusSensitivity and SpecificitySerologic TestsAntibodies, MonoclonalAntibodies, ViralAntigens, ViralNucleocapsid Proteins

Identifiers

PMID27045364
PMCPMC4821557
OpenAlexW2325954924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.